1. Describe relationships between markers of CKD severity and outcomes.
2. Weigh accumulating evidence for novel biomarkers for CKD and CVD in patients with CKD and kidney transplant recipients.
09/27/2018 - 1:00pm to 2:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Brad Astor, PhD, MPH